Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
Top Cited Papers
- 1 December 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 40 (6) , 897-902
- https://doi.org/10.1161/01.hyp.0000038478.59760.41
Abstract
Primary aldosteronism is a specifically treatable and potentially curable form of secondary hypertension. The aldosterone/plasma renin activity ratio (ARR) is routinely used as a screening test. Antihypertensive therapy can interfere with the interpretation of this parameter, but a correct washout period can be potentially harmful. We have investigated the effects of therapy with atenolol, amlodipine, doxazosin, fosinopril, and irbesartan on the ARR in a group of 230 patients with suspected primary aldosteronism. The percent change from control of ARR in patients taking amlodipine was −17%±32; atenolol, 62%±82; doxazosin, −5%±26; fosinopril, −30%±24; and irbesartan, −43%±27. The ARR change induced by atenolol was significantly higher compared with that induced by all other drugs ( P P <0.0001). One of 55 patients from the group taking amlodipine (1.8%) and 4/17 of the patients taking irbesartan (23.5%) gave a false-negative ARR (<50). None of the patients of the groups taking fosinopril, doxazosin, and atenolol displayed a false-negative ARR. Doxazosin and fosinopril can be used in hypertensive patients who need to undergo aldosterone and PRA measurement for the diagnosis of primary aldosteronism; amlodipine gave a very small percentage of false-negative diagnoses. β-Blockers also do not interfere with the diagnosis of primary aldosteronism, but they can be responsible for an increased rate of false-positive ARRs. The high rate of false-negative diagnoses in patients undergoing irbesartan treatment requires confirmation in a higher number of patients.Keywords
This publication has 28 references indexed in Scilit:
- Review: Diagnosis and management of primary aldosteronismJournal of the Renin-Angiotensin-Aldosterone System, 2001
- Establishing a diagnosis of primary hyperaldosteronismCurrent Opinion in Endocrinology, Diabetes and Obesity, 2001
- Primary AldosteronismCardiology in Review, 1999
- Primary Aldosteronism: Update on Diagnosis and TreatmentThe Endocrinologist, 1997
- HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSIONClinical and Experimental Pharmacology and Physiology, 1994
- EVIDENCE THAT PRIMARY ALDOSTERONISM MAY NOT BE UNCOMMON: 12% INCIDENCE AMONG ANTIHYPERTENSIVE DRUG TRIAL VOLUNTEERSClinical and Experimental Pharmacology and Physiology, 1993
- Evidence for a tonic inhibitory role of nifedipine-sensitive calcium channels in aldosterone biosynthesisThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Effects of doxazosin on blood pressure, renin-angiotensin-aldosterone and urinary kallikreinThe American Journal of Cardiology, 1991
- Further evaluation of saline infusion for the diagnosis of primary aldosteronism.Hypertension, 1984
- Prolonged Clonidine Treatment: Catecholamines, Renin Activity and Aldosterone Following Exercise in HypertensivesActa Medica Scandinavica, 1981